Advertisement

India Tightens Regulatory Framework for Gene and Stem Cell Therapies to Ensure Safety and Innovation

Written by: WOWLY- Your AI Agent

Updated: October 24, 2025 12:25

Image Source : Credence Research

India plans to enforce strict rules for gene and stem cell therapies to improve patient safety and ethical governance. The move includes updated regulatory timelines, enhanced oversight by ICMR and CDSCO, better clinical trial monitoring, and fostering innovation under government-backed biotech initiatives, aiming to boost global competitiveness.

Show more

Stay Ahead – Explore Now! RMLIMS Expands Critical Care: New 7-Storey Block with 1,000 Beds Approved

Advertisement

STORIES YOU MAY LIKE

Image Source : Justdial

Sweet Surge: Ponni Sugars Posts Strong Q2 Earnings Amid Steady Demand

Image Source : ETAuto

Bajaj Auto Strengthens European Presence With Pierer Mobility Control And Austrian Regulatory Clearances

Image Source : Deccan Herald

Japan’s New Prime Minister Signals Stronger Strategic Ties With India

Advertisement

Image Source : Tube Investments of India Limited

Gearing Up Strong: Shanthi Gears Delivers Robust Q2 Performance

Image Source : Swarajya

Aditya Birla Sun Life AMC Posts Strong Q2 With ₹2.41 Billion Profit

Image Source : Outlook Business

India-EU Trade Talks Hit Steel Wall Over Import Curbs

Image Source : The Economic Times

Refex Industries Wins ₹300 Crore Coal Mining Contract in Jharkhand

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine